Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ledum palustre, also known by its botanical name *Rhododendron tomentosum*, is a plant-derived substance used primarily in homeopathic medicine. It is traditionally indicated for the treatment of ecchymosis (bruising), puncture wounds, and insect stings. In clinical development, it has been evaluated by companies like Cearna, Inc. as part of a topical formulation (often in combination with *Arnica montana*) to reduce the severity and duration of bruising following mechanical injury or surgical procedures. The plant contains volatile oils, including the sesquiterpene alcohol ledol, as well as various flavonoids and tannins, which are thought to contribute to its purported anti-inflammatory and anti-edematous effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ledum palustre.